recombin
nucleocapsid
rn
protein
coronaviru
cov
respons
sever
acut
respiratori
syndrom
sar
clone
express
escherichia
coli
extract
cell
lysat
contain
urea
purifi
ni
affin
chromatographi
anim
immunogen
studi
found
antirn
protein
antibodi
balbc
mice
vaccin
rn
emulsifi
montanid
contain
synthet
oligodeoxynucleotid
cpg
contrast
antirn
protein
antibodi
mice
immun
rn
protein
pb
found
mainli
result
indic
rn
protein
dramat
bias
toward
immun
respons
identifi
bcell
immunodomin
epitop
rn
protein
mous
monkey
reactiv
antisera
rais
purifi
rn
protein
formul
test
panel
overlap
synthet
peptid
cover
entir
n
protein
sequenc
three
immunodomin
linear
bcell
epitop
region
map
residu
rn
protein
reactiv
peptid
screen
human
sera
five
sar
patient
peptid
correspond
residu
react
strongli
sera
two
sar
patient
result
indic
region
around
residu
n
protein
immunogen
mous
monkey
human
found
peptid
correspond
residu
contain
murin
immunodomin
tcell
epitop
identifi
function
ctl
epitop
n
protein
balbc
mice
immun
peptid
contain
ctl
motif
emulsifi
adjuv
use
secret
cell
assay
analysi
flow
cytometri
peptid
contain
residu
found
capabl
stimul
cell
prolifer
vitro
also
observ
peptid
correspond
residu
capabl
stimul
product
tcell
cultur
deriv
peripher
blood
mononuclear
cell
pbmc
macaqu
immun
rn
protein
emulsifi
isacpg
adjuv
current
result
togeth
other
suggest
immunodomin
bcell
tcell
epitop
conserv
mous
monkey
human
inform
import
develop
sar
diagnost
kit
vaccin
newli
emerg
infecti
diseas
caus
sever
acut
respiratori
syndromeassoci
coronaviru
sar
cov
signific
econom
impact
countri
affect
diseas
outbreak
lack
effici
treatment
prevent
mean
possibl
exist
sar
return
futur
addit
highrisk
popul
laboratori
hospit
worker
need
effect
sar
vaccin
protect
unfortun
recent
report
shown
inactiv
coronaviru
vaccin
cat
model
might
worsen
diseas
rather
prevent
furthermor
sar
viru
may
caus
mild
liver
inflamm
ferret
damag
much
seriou
anim
first
given
candid
sar
vaccin
base
vaccinia
viru
yang
et
al
also
found
antibodi
sar
cov
protein
enhanc
entri
viru
vitro
cell
cultur
studi
therefor
order
gener
safe
effect
sar
vaccin
urgent
need
greater
understand
immunolog
respons
vaccin
candid
differ
anim
model
n
protein
felin
infecti
periton
viru
fipv
use
subunit
vaccin
induc
protect
immun
prevent
progress
diseas
cat
model
literatur
indic
immun
dna
plasmid
encod
n
protein
ebola
viru
influenza
viru
elicit
protect
antigenspecif
cytotox
lymphocyt
ctl
respons
avian
coronavirus
n
proteinspecif
tcell
respons
shown
gener
protect
immun
result
indic
good
n
protein
vaccin
candid
elicit
strong
cellular
immun
respons
n
protein
sar
cov
amino
acid
long
highli
conserv
within
differ
isol
share
amino
acid
homolog
n
protein
coronavirus
fact
dna
vaccin
candid
encod
n
protein
sar
cov
fuse
calreticulin
crt
shown
induc
potent
humor
cellular
immun
respons
mous
model
inhibit
replic
recombin
vaccinia
viru
express
n
protein
vivo
therefor
focus
n
protein
sar
cov
target
antigen
subunit
vaccin
develop
eye
toward
clinic
applic
select
two
potenti
adjuv
clinic
use
shown
strong
cellular
immun
respons
induc
montanid
immunestimul
oligonucleotid
cpg
cpg
use
emulsifi
rn
protein
vaccin
candid
mous
macaqu
immunogen
studi
present
studi
report
rn
protein
dramat
bias
toward
immun
respons
immunodomin
band
tcell
epitop
n
protein
present
balbc
mice
macaqu
conserv
immunodomin
bcell
epitop
identifi
mice
macaqu
sar
patient
n
proteinspecif
cell
could
induc
formul
either
rn
protein
synthet
peptid
contain
ctl
epitop
motif
recombin
sar
cov
n
protein
rn
contain
ntermin
tag
gene
clone
prseta
vector
invitrogen
carlsbad
ca
usa
protein
express
plasmid
transform
escherichia
coli
gold
stratagen
cedar
creek
tx
usa
host
strain
incub
c
overnight
express
rn
induc
mm
isopropyl
iptg
h
cell
harvest
centrifug
g
min
cell
pellet
resuspend
ml
homogen
buffer
mm
triscl
ph
mm
nacl
glycerol
mm
sucros
mm
imidazol
disrupt
use
french
press
constant
system
daventri
uk
mpa
cell
lysat
clarifi
centrifug
g
min
target
protein
extract
pellet
urea
homogen
buffer
load
ml
ninta
resin
qiagen
san
diego
ca
usa
resin
wash
buffer
target
protein
purifi
chang
ph
valu
wash
ph
homogen
buffer
urea
rn
elut
resin
use
ph
homogen
buffer
urea
purifi
rn
refold
dialyz
phosphatebuff
salin
pb
purifi
rn
store
c
pb
glycerol
studi
analyz
sampl
sdspage
l
sampl
mix
equal
volum
sampl
buffer
mm
trishcl
ph
sd
glycerol
bromophenol
blue
heat
boil
water
min
sampl
g
protein
per
lane
separ
sdspage
electrophoret
transfer
gel
polyvinyliden
difluorid
pvdf
membran
millipor
billerica
usa
min
membran
block
overnight
nonfat
milk
pb
contain
pbst
c
wash
pbst
blot
incub
room
temperatur
h
mous
antihi
antibodi
dilut
amersham
bioscienc
new
territori
hk
extens
wash
pbst
incub
h
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
bethyl
laboratori
montgomeri
tx
usa
blot
develop
mm
dab
diaminobenzidin
tetrahydrochlorid
sigma
st
loui
mo
usa
develop
min
blot
wash
distil
water
stop
reaction
sixto
eightweek
old
femal
balbc
mice
obtain
nation
laboratori
anim
breed
research
center
taipei
taiwan
mice
hous
anim
technolog
institut
taiwan
atit
miaoli
taiwan
anim
facil
monkey
formosan
macaqu
macaca
cyclopi
maintain
accord
institut
anim
care
protocol
center
diseas
control
taipei
taiwan
anim
studi
approv
anim
committe
nation
health
research
institut
taipei
taiwan
peptid
deriv
sar
cov
n
protein
sequenc
synthes
fragment
overlap
cover
entir
n
protein
sequenc
urbani
strain
kelowna
taipei
taiwan
peptid
dissolv
dmso
mgml
two
ctl
epitop
qfkdnvill
vwvateg
produc
n
protein
bablc
mice
class
bind
motif
predict
computerbas
program
web
site
bioinformat
molecular
analysi
section
bethesda
md
usa
mice
immun
subcutan
g
rn
protein
emulsifi
incomplet
freund
adjuv
ifa
montanid
seppic
pari
franc
g
cpg
oligonucleotid
tcg
tcg
ttt
tgt
cgt
ttt
gtc
gtt
ttg
tcg
tt
mice
receiv
two
booster
dose
immunogen
one
week
later
blood
sampl
collect
everi
week
postimmun
tcell
analysi
mice
sacrif
day
final
immun
pool
peptid
group
peptid
tabl
contain
restrict
epitop
emulsifi
ifa
cpg
oligonucleotid
isacpg
immun
subcutan
monkey
experi
g
rn
emulsifi
ml
isacpg
multipl
inject
given
muscularli
week
sera
collect
specifi
time
point
sera
obtain
clot
blood
sampl
centrifug
heatinactiv
c
min
sera
five
convalescentphas
human
obtain
center
diseas
control
taipei
taiwan
sera
collect
day
recoveri
diseas
base
clinic
diagnosi
sera
inactiv
follow
govern
guidelin
transfer
laboratori
presenc
n
proteinor
peptidespecif
antibodi
sera
determin
elisa
briefli
l
gml
purifi
rn
peptid
coat
microtit
plate
carbon
buffer
ph
overnight
incub
c
coat
plate
wash
twice
pbst
block
nonfat
milk
pb
room
temperatur
h
dilut
sera
immun
anim
appli
well
room
temperatur
h
follow
hrpconjug
goat
antimous
igg
hrpconjug
goat
antimonkey
igg
sigma
st
loui
mo
usa
assay
develop
tmb
reaction
stop
ad
l
h
per
well
plate
read
nm
use
elisa
plate
reader
molecular
devic
sunnyval
ca
usa
antibodi
isotyp
analysi
biotinconjug
rat
antimous
bd
pharmingen
san
diego
ca
usa
ad
well
sera
bind
hrpconjug
streptavidin
ad
develop
tmb
substrat
antibodi
titer
defin
reciproc
highest
dilut
produc
valu
twofold
higher
preimmun
sera
day
final
immun
mice
sacrif
harvest
spleen
erythrocytedeplet
splenocyt
cellswel
plate
cultur
vitro
gml
pool
peptid
individu
peptid
cover
n
protein
amino
acid
plate
h
cell
detect
mous
secret
assay
detect
kit
miltenyi
biotec
gladbach
germani
brief
splenocyt
harvest
label
captur
antibodi
min
c
afterward
cell
transfer
c
warm
medium
min
wash
twice
stain
phycoerythrin
pe
conjug
detect
reagent
fluorescein
isothiocyan
fitc
conjug
antibodi
wash
cell
collect
analyz
facscalibur
instrument
cellquest
softwar
dead
cell
gate
gml
propidium
iodid
tcell
epitop
map
perform
mice
monkey
immun
purifi
rn
g
respect
emulsifi
plu
g
cpg
oligonucleotid
seven
day
second
boost
splenocyt
mice
peripher
blood
mononuclear
cell
pbmc
monkey
cellswel
cultur
rpmi
gibco
san
diego
ca
usa
supplement
heatinactiv
fetal
calf
serum
uml
penicillin
gml
streptomycin
gml
pool
individu
peptid
c
day
concanavalin
con
medium
alon
serv
posit
background
control
respect
supernat
harvest
assay
cytokin
product
mous
quantit
elisa
use
match
antibodi
set
r
system
minneapoli
mn
usa
accord
manufactur
direct
monkey
measur
use
elisa
kit
biosourc
intern
camarillo
ca
usa
accord
manufactur
protocol
data
evalu
use
student
ttest
analysi
varianc
anova
determin
statist
signific
differ
sampl
p
consid
statist
signific
abil
certain
individu
overcom
infect
without
treatment
led
hypothesi
administr
vaccin
sar
may
provid
effect
protect
diseas
like
virus
spike
protein
viral
surfac
coronavirus
shown
elicit
enhanc
diseas
nonneutr
spike
proteinspecif
antibodi
vaccin
elicit
tcell
immun
sar
protein
like
receiv
morefavor
clinic
attent
anim
coronaviru
vaccin
develop
n
protein
wide
test
immunogen
protect
coronaviru
infect
inocul
chicken
plasmid
dna
encod
infecti
bronchiti
viru
ibv
carboxyl
terminu
n
protein
led
induct
specif
cytotox
lymphocyt
popul
capabl
recogn
two
distinct
ibv
strain
addit
adopt
transfer
cell
anim
inocul
ibv
chick
provid
specif
protect
tcell
line
resist
murin
hepat
viru
mhv
show
mark
increas
express
decreas
product
incub
mhvinfect
cell
infus
resist
cell
line
suscept
mice
led
complet
protect
mhv
infect
immun
mhv
demonstr
process
depend
upon
perforin
absenc
cell
gener
antibodi
follow
dna
immun
n
protein
suggest
signific
respons
strong
potenti
protect
immun
n
proteinbas
vaccin
hypothes
sar
cov
n
protein
would
elicit
effect
immun
respons
sar
diseas
aid
downstream
purif
process
ctermin
end
n
proteincod
region
tag
six
histidin
residu
express
rn
protein
could
induc
ad
mm
isopropyl
iptg
e
coli
cell
cultur
level
express
observ
use
sdspage
analysi
fig
lane
electrophoret
posit
rn
protein
correspond
predict
size
kda
rn
protein
collect
pellet
cell
lysat
use
centrifug
rn
protein
purifi
use
imac
immobil
metal
affin
chromatographi
column
ph
stepwis
gradient
contain
urea
fig
lane
purifi
rn
protein
refold
dialysi
pb
could
detect
blot
antihi
antibodi
fig
obtain
mg
purifi
rn
protein
l
cell
cultur
repres
overal
yield
mention
strong
adjuv
elicit
strong
cellular
immun
respons
necessari
n
protein
effect
vaccin
candid
differ
adjuv
formul
induc
differ
immun
respons
immun
anim
assess
immun
respons
elicit
rn
protein
balbc
mous
model
rn
protein
formul
either
incomplet
freund
adjuv
ifa
potent
adjuv
complex
isacpg
pb
alon
three
immun
g
rn
protein
per
dose
n
proteinspecif
antibodi
respons
measur
use
elisa
result
shown
fig
antibodi
titer
found
isacpg
ifa
pb
group
respect
test
whether
strong
immun
respons
elicit
rn
protein
formul
isacpg
use
clinic
applic
analyz
subtyp
reactiv
antibodi
group
isotyp
gener
differ
group
shown
fig
antibodi
found
pb
group
less
similar
titer
found
ifa
isacpg
group
surprisingli
isacpg
group
gener
strong
domin
antibodi
ifa
group
produc
less
result
indic
isacpg
could
drive
immun
respons
toward
consist
previou
result
show
synthet
oligodeoxynucleotid
cpg
motif
could
skew
host
immun
respons
toward
combin
cpg
also
show
abil
enhanc
protect
efficaci
subunit
malaria
vaccin
candid
identif
immunodomin
b
cell
epitop
could
use
futur
immunolog
investig
identifi
bcell
epitop
n
protein
mice
immun
rn
protein
formul
either
ifa
isacpg
system
analyz
bcell
epitop
peptid
pool
consist
consecut
overlap
peptid
n
protein
use
screen
antin
antisera
see
tabl
peptideelisa
assay
use
rn
protein
posit
control
intern
standard
normal
reactiv
sinc
desir
determin
immunodomin
epitop
mous
sera
dilut
epitop
screen
mous
antisera
gener
group
immun
rn
protein
formul
ifa
found
two
major
reactiv
peptid
pool
individu
peptid
reactiv
analysi
show
peptid
contain
immunodomin
epitop
fig
isacpgimmun
mous
group
two
major
reactiv
peptid
pool
individu
peptid
screen
found
major
reactiv
peptid
eighti
overlap
peptid
cover
entir
sequenc
sar
cov
n
protein
use
elisa
measur
immunodomin
linear
bcell
epitop
rel
reactiv
peptid
test
sera
calcul
use
mean
od
peptid
divid
mean
od
peptid
sampl
time
rel
reactiv
consid
posit
no
fig
regardless
adjuv
use
result
show
balbc
mous
immunodomin
bcell
epitop
locat
ctermin
region
peptid
howev
sera
balbc
mice
immun
sar
viru
recogn
ntermin
region
residu
n
protein
differ
result
could
due
natur
antigen
refold
rn
protein
versu
inactiv
sar
viru
adjuv
use
sinc
rn
protein
formul
isacpg
provid
best
immun
respons
mous
model
select
adjuv
macaqu
immunogen
studi
sera
two
immun
macaqu
reactiv
titer
rn
protein
accord
elisa
data
shown
immunodomin
bcell
epitop
identif
macaqu
sera
dilut
screen
reactiv
peptid
pool
serum
monkey
recogn
peptid
pool
serum
monkey
react
peptid
pool
identifi
reactiv
peptid
found
peptid
contain
immunodomin
bcell
epitop
peptid
pool
sinc
recogn
antisera
macaqu
also
peptid
found
contain
macaqu
immunodomin
bcell
epitop
peptid
peptid
pool
shown
reactiv
serum
monkey
fig
result
describ
conserv
immunodomin
bcell
epitop
mice
monkey
locat
within
peptid
residu
residu
residu
residu
studi
bcell
epitop
n
protein
recogn
sar
patient
sera
patient
sera
dilut
use
screen
reactiv
peptid
pool
found
two
patient
sera
react
peptid
pool
purifi
np
data
shown
five
randomli
select
patient
sera
individu
peptid
screen
major
reactiv
peptid
found
peptid
correspond
residu
fig
result
consist
previou
report
shichijo
et
al
et
al
guo
et
al
also
found
region
around
residu
react
sera
sar
patient
summar
data
fig
show
immunodomin
bcell
epitop
correspond
residu
conserv
mice
macaqu
interestingli
region
correspond
residu
found
contain
bcell
epitop
three
speci
region
residu
use
diagnost
kit
develop
biomark
vaccin
develop
well
murin
tcell
epitop
identifi
use
vitro
stimulatori
effect
overlap
peptid
cell
deriv
splenocyt
balbc
mice
immun
rn
protein
formul
either
ifa
isacpg
adjuv
amount
secret
cultur
supernat
determin
elisa
kit
detect
pb
serv
control
group
data
shown
shown
fig
product
observ
ifaand
isacpgimmun
group
sever
differ
peptid
found
capabl
stimul
secret
potenti
tcell
epitop
found
ifa
group
correspond
residu
isacpg
group
tcell
reactiv
region
identifi
residu
peptid
residu
residu
found
stimul
product
immun
group
although
could
determin
restrict
ctl
epitop
natur
sar
cov
infect
seem
like
residu
use
indic
studi
tcell
respons
n
protein
subunit
vaccin
interestingli
peptid
contain
potenti
balbc
mous
ctl
epitop
yyrratrrv
identifi
epitop
predict
algorithm
macaqu
immunodomin
tcell
epitop
map
also
perform
pbmc
isol
two
macaqu
vaccin
twice
rn
protein
formul
isacpg
found
product
tcell
cultur
deriv
pbmc
fig
studi
observ
peptid
residu
gaiklddkdpqfkdn
capabl
stimul
product
tcell
cultur
deriv
pbmc
monkey
result
could
import
inform
sar
vaccin
evalu
especi
macaqu
infect
model
human
immunodomin
tcell
epitop
identif
studi
de
et
al
publish
elsewher
also
found
peptid
elicit
respons
cell
deriv
pbmc
two
sar
patient
class
haplotyp
find
suggest
rn
protein
formul
isacpg
adjuv
elicit
tcell
immun
respons
may
import
protect
immun
sar
diseas
addit
bcell
respons
ctl
may
play
import
role
virusinfect
cell
clearanc
computerbas
program
bima
hla
peptid
bind
predict
program
use
predict
candid
ctl
peptid
n
protein
two
peptid
qfkdnvill
vwvateg
identifi
synthes
base
highest
score
valu
tabl
two
peptid
mix
formul
isacpg
adjuv
six
peptid
n
protein
identifi
consist
ctlbind
epitop
day
third
immun
splenocyt
balbc
mice
harvest
variou
peptid
ad
splenocyt
cultur
vitro
stimul
day
cytokin
secret
measur
use
cytokinespecif
elisa
peptid
pddqigyyrratrrv
observ
capabl
stimul
product
pgml
fig
result
tcell
epitop
map
describ
confirm
yyrratrrv
potent
function
tcell
epitop
order
analyz
reactiv
tcell
subset
restimul
splenocyt
peptid
presenc
uml
recombin
h
twocolor
flow
cytometr
analysi
tcell
subset
stain
reveal
tcell
popul
reactiv
peptid
isol
splenocyt
plate
stimul
gml
peptid
number
repres
top
two
rank
nonam
peptid
respect
see
tabl
peptid
order
base
predict
score
b
posit
well
cultur
correspond
peptid
gml
c
day
presenc
uml
cultur
cell
restimul
correspond
peptid
c
h
cell
analyz
flow
cytometri
concentr
cell
found
respect
fig
lower
cell
popul
perhap
due
peptid
peptid
might
best
match
mhc
class
prefer
peptid
length
peptid
conclus
demonstr
mous
macaqu
model
rn
protein
formul
potenti
clinic
use
adjuv
cpg
elicit
strong
immun
respons
may
excel
sar
vaccin
candid
human
band
tcell
immunodomin
epitop
n
protein
also
found
mice
macaqu
immun
rn
protein
formul
isacpg
adjuv
conserv
immunodomin
epitop
identifi
three
speci
provid
import
inform
vaccin
design
